Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Freeman

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|May 8, 2007
Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut modelJane Freeman, Simon D Baines, Katie Saxton, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2006
Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut modelSimon D Baines, Katie Saxton, Jane Freeman, et al.
The Journal of Antimicrobial Chemotherapy|September 7, 2005
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infectionJane Freeman, Simon D Baines, Daniela Jabes, et al.
Mededpublish (2016)|December 11, 2023
Managing the COVID-19 risk: the practicalities of delivering high stakes OSCEs during a pandemicClaire Ann Canning, Kirsty Jane Freeman, Ian Curran, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2008
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancinRachael O'Connor, Simon D Baines, Jane Freeman, et al.
Anaerobe|March 21, 2025
Molecular clock complexities of Clostridioides difficileJon J Vernon, David W Eyre, Mark H Wilcox, et al.
Journal of Clinical Microbiology|June 16, 2005
Molecular epidemiology of endemic Clostridium difficile infection and the significance of subtypes of the United Kingdom epidemic strain (PCR ribotype 1)Warren N Fawley, Peter Parnell, Paul Verity, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2008
Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut modelKatie Saxton, Simon D Baines, Jane Freeman, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2008
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut modelSimon D Baines, Rachel O'Connor, Katie Saxton, et al.
The Journal of Antimicrobial Chemotherapy|September 6, 2008
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut modelSimon D Baines, Rachael O'Connor, Katie Saxton, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|May 8, 2007
Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut modelJane Freeman, Simon D Baines, Katie Saxton, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2006
Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut modelSimon D Baines, Katie Saxton, Jane Freeman, et al.
The Journal of Antimicrobial Chemotherapy|September 7, 2005
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infectionJane Freeman, Simon D Baines, Daniela Jabes, et al.
Mededpublish (2016)|December 11, 2023
Managing the COVID-19 risk: the practicalities of delivering high stakes OSCEs during a pandemicClaire Ann Canning, Kirsty Jane Freeman, Ian Curran, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2008
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancinRachael O'Connor, Simon D Baines, Jane Freeman, et al.
Anaerobe|March 21, 2025
Molecular clock complexities of Clostridioides difficileJon J Vernon, David W Eyre, Mark H Wilcox, et al.
Journal of Clinical Microbiology|June 16, 2005
Molecular epidemiology of endemic Clostridium difficile infection and the significance of subtypes of the United Kingdom epidemic strain (PCR ribotype 1)Warren N Fawley, Peter Parnell, Paul Verity, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2008
Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut modelKatie Saxton, Simon D Baines, Jane Freeman, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2008
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut modelSimon D Baines, Rachel O'Connor, Katie Saxton, et al.
The Journal of Antimicrobial Chemotherapy|September 6, 2008
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut modelSimon D Baines, Rachael O'Connor, Katie Saxton, et al.
Pageof 6